Renaissance Technologies LLC lowered its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 62.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 30,500 shares of the real estate investment trust's stock after selling 51,700 shares during the quarter. Renaissance Technologies LLC owned 0.07% of National Health Investors worth $2,114,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in NHI. Loomis Sayles & Co. L P grew its position in National Health Investors by 42.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock worth $44,000 after buying an additional 189 shares during the period. State of Alaska Department of Revenue raised its stake in shares of National Health Investors by 1.0% during the 4th quarter. State of Alaska Department of Revenue now owns 20,040 shares of the real estate investment trust's stock worth $1,388,000 after buying an additional 196 shares during the last quarter. Pictet Asset Management Holding SA lifted its holdings in shares of National Health Investors by 1.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 13,197 shares of the real estate investment trust's stock valued at $915,000 after purchasing an additional 238 shares in the last quarter. Tidal Investments LLC grew its position in shares of National Health Investors by 3.9% in the third quarter. Tidal Investments LLC now owns 6,762 shares of the real estate investment trust's stock valued at $568,000 after purchasing an additional 254 shares during the last quarter. Finally, Xponance Inc. increased its stake in shares of National Health Investors by 9.5% during the 4th quarter. Xponance Inc. now owns 2,997 shares of the real estate investment trust's stock worth $208,000 after purchasing an additional 259 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
National Health Investors Trading Down 0.4 %
NHI traded down $0.30 during midday trading on Tuesday, hitting $74.84. The company's stock had a trading volume of 258,049 shares, compared to its average volume of 221,627. The firm has a market cap of $3.49 billion, a P/E ratio of 25.72, a PEG ratio of 4.42 and a beta of 0.79. National Health Investors, Inc. has a 52-week low of $62.61 and a 52-week high of $86.13. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm has a 50-day moving average price of $73.26 and a two-hundred day moving average price of $72.77.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.03. The company had revenue of $85.75 million for the quarter, compared to the consensus estimate of $81.13 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. On average, research analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 4.81%. The ex-dividend date of this dividend is Monday, March 31st. National Health Investors's dividend payout ratio (DPR) is presently 115.38%.
Analyst Upgrades and Downgrades
Several research firms have weighed in on NHI. Truist Financial raised their price target on National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a research report on Wednesday, March 19th. Wedbush reissued an "outperform" rating and issued a $88.00 target price on shares of National Health Investors in a research note on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, National Health Investors has a consensus rating of "Hold" and an average target price of $85.50.
Read Our Latest Research Report on National Health Investors
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
